CN106248860A - A kind of detection method of ERPIXING KELI - Google Patents
A kind of detection method of ERPIXING KELI Download PDFInfo
- Publication number
- CN106248860A CN106248860A CN201610887034.6A CN201610887034A CN106248860A CN 106248860 A CN106248860 A CN 106248860A CN 201610887034 A CN201610887034 A CN 201610887034A CN 106248860 A CN106248860 A CN 106248860A
- Authority
- CN
- China
- Prior art keywords
- solution
- take
- methanol
- reference substance
- chromatograph
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001514 detection method Methods 0.000 title claims abstract description 55
- 238000012360 testing method Methods 0.000 claims abstract description 137
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 114
- 238000000034 method Methods 0.000 claims abstract description 66
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims abstract description 55
- 229940025878 hesperidin Drugs 0.000 claims abstract description 55
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims abstract description 54
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims abstract description 54
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims abstract description 54
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims abstract description 54
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims abstract description 54
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims abstract description 54
- 238000003556 assay Methods 0.000 claims abstract description 33
- 210000003038 endothelium Anatomy 0.000 claims abstract description 28
- 238000012850 discrimination method Methods 0.000 claims abstract description 22
- 239000003814 drug Substances 0.000 claims abstract description 19
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 240000008669 Hedera helix Species 0.000 claims abstract description 5
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims abstract description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 336
- 239000000243 solution Substances 0.000 claims description 237
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 141
- 239000013558 reference substance Substances 0.000 claims description 109
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 96
- 239000000523 sample Substances 0.000 claims description 94
- 239000000463 material Substances 0.000 claims description 89
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 81
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 74
- 239000007788 liquid Substances 0.000 claims description 64
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical class CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 claims description 56
- 239000008187 granular material Substances 0.000 claims description 51
- 239000000203 mixture Substances 0.000 claims description 46
- 239000000706 filtrate Substances 0.000 claims description 45
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 42
- 239000012467 final product Substances 0.000 claims description 36
- 239000002904 solvent Substances 0.000 claims description 36
- 238000002360 preparation method Methods 0.000 claims description 35
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 32
- 239000000741 silica gel Substances 0.000 claims description 32
- 229910002027 silica gel Inorganic materials 0.000 claims description 32
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 31
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims description 28
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 27
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- 239000007921 spray Substances 0.000 claims description 24
- 238000010992 reflux Methods 0.000 claims description 23
- 238000004809 thin layer chromatography Methods 0.000 claims description 21
- 239000000945 filler Substances 0.000 claims description 20
- 239000000377 silicon dioxide Substances 0.000 claims description 20
- 238000011161 development Methods 0.000 claims description 18
- YTJSFYQNRXLOIC-UHFFFAOYSA-N octadecylsilane Chemical compound CCCCCCCCCCCCCCCCCC[SiH3] YTJSFYQNRXLOIC-UHFFFAOYSA-N 0.000 claims description 18
- 239000007864 aqueous solution Substances 0.000 claims description 16
- 229960000583 acetic acid Drugs 0.000 claims description 15
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims description 14
- 235000019253 formic acid Nutrition 0.000 claims description 14
- 239000000284 extract Substances 0.000 claims description 13
- 238000004811 liquid chromatography Methods 0.000 claims description 13
- 238000002156 mixing Methods 0.000 claims description 12
- 229940096998 ursolic acid Drugs 0.000 claims description 11
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 10
- 239000012362 glacial acetic acid Substances 0.000 claims description 10
- 238000000527 sonication Methods 0.000 claims description 10
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 9
- FEMOMIGRRWSMCU-UHFFFAOYSA-N ninhydrin Chemical compound C1=CC=C2C(=O)C(O)(O)C(=O)C2=C1 FEMOMIGRRWSMCU-UHFFFAOYSA-N 0.000 claims description 9
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 claims description 9
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 8
- 239000003480 eluent Substances 0.000 claims description 8
- 238000011067 equilibration Methods 0.000 claims description 8
- 230000007935 neutral effect Effects 0.000 claims description 8
- NJGHBZYAEWVDMY-UHFFFAOYSA-K ethanol;trichloroalumane Chemical compound [Al+3].[Cl-].[Cl-].[Cl-].CCO NJGHBZYAEWVDMY-UHFFFAOYSA-K 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 239000001117 sulphuric acid Substances 0.000 claims description 6
- 235000011149 sulphuric acid Nutrition 0.000 claims description 6
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 5
- 239000012567 medical material Substances 0.000 claims description 5
- 239000012047 saturated solution Substances 0.000 claims description 4
- 241000675108 Citrus tangerina Species 0.000 claims description 3
- 229930006000 Sucrose Natural products 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- LFVGISIMTYGQHF-UHFFFAOYSA-N ammonium dihydrogen phosphate Chemical compound [NH4+].OP(O)([O-])=O LFVGISIMTYGQHF-UHFFFAOYSA-N 0.000 claims description 3
- 229910000387 ammonium dihydrogen phosphate Inorganic materials 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 239000003795 chemical substances by application Substances 0.000 claims description 3
- 235000019837 monoammonium phosphate Nutrition 0.000 claims description 3
- 238000005325 percolation Methods 0.000 claims description 3
- 238000001556 precipitation Methods 0.000 claims description 3
- 238000004064 recycling Methods 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 235000019640 taste Nutrition 0.000 claims description 3
- 241000287828 Gallus gallus Species 0.000 claims description 2
- UGAPHEBNTGUMBB-UHFFFAOYSA-N acetic acid;ethyl acetate Chemical compound CC(O)=O.CCOC(C)=O UGAPHEBNTGUMBB-UHFFFAOYSA-N 0.000 claims description 2
- 239000002024 ethyl acetate extract Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000004611 spectroscopical analysis Methods 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 239000002893 slag Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 8
- 229940079593 drug Drugs 0.000 abstract description 5
- 239000000047 product Substances 0.000 description 23
- 238000000605 extraction Methods 0.000 description 22
- 239000003153 chemical reaction reagent Substances 0.000 description 16
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 12
- 238000010200 validation analysis Methods 0.000 description 12
- 239000012488 sample solution Substances 0.000 description 10
- 206010061428 decreased appetite Diseases 0.000 description 8
- 208000022531 anorexia Diseases 0.000 description 7
- 230000004044 response Effects 0.000 description 7
- 239000002253 acid Substances 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 238000011084 recovery Methods 0.000 description 5
- 238000010521 absorption reaction Methods 0.000 description 4
- -1 biphosphate Ammonium salt Chemical class 0.000 description 4
- 239000012535 impurity Substances 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241001092040 Crataegus Species 0.000 description 3
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 3
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 3
- 235000009685 Crataegus X maligna Nutrition 0.000 description 3
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 3
- 235000009486 Crataegus bullatus Nutrition 0.000 description 3
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 3
- 235000009682 Crataegus limnophila Nutrition 0.000 description 3
- 235000004423 Crataegus monogyna Nutrition 0.000 description 3
- 235000002313 Crataegus paludosa Nutrition 0.000 description 3
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- XHFLOLLMZOTPSM-UHFFFAOYSA-M sodium;hydrogen carbonate;hydrate Chemical compound [OH-].[Na+].OC(O)=O XHFLOLLMZOTPSM-UHFFFAOYSA-M 0.000 description 3
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 240000004307 Citrus medica Species 0.000 description 2
- 235000002710 Ilex cornuta Nutrition 0.000 description 2
- 241001310146 Ilex cornuta Species 0.000 description 2
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- PQLVXDKIJBQVDF-UHFFFAOYSA-N acetic acid;hydrate Chemical compound O.CC(O)=O PQLVXDKIJBQVDF-UHFFFAOYSA-N 0.000 description 2
- 150000001343 alkyl silanes Chemical group 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000010812 external standard method Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- DHRLEVQXOMLTIM-UHFFFAOYSA-N phosphoric acid;trioxomolybdenum Chemical compound O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.O=[Mo](=O)=O.OP(O)(O)=O DHRLEVQXOMLTIM-UHFFFAOYSA-N 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000012266 salt solution Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000013112 stability test Methods 0.000 description 2
- 239000012085 test solution Substances 0.000 description 2
- 230000001550 time effect Effects 0.000 description 2
- 208000000103 Anorexia Nervosa Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 201000009495 Hypotrichosis Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- AOZUYISQWWJMJC-UHFFFAOYSA-N acetic acid;methanol;hydrate Chemical compound O.OC.CC(O)=O AOZUYISQWWJMJC-UHFFFAOYSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- FFBHFFJDDLITSX-UHFFFAOYSA-N benzyl N-[2-hydroxy-4-(3-oxomorpholin-4-yl)phenyl]carbamate Chemical compound OC1=C(NC(=O)OCC2=CC=CC=C2)C=CC(=C1)N1CCOCC1=O FFBHFFJDDLITSX-UHFFFAOYSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- SIHHLZPXQLFPMC-UHFFFAOYSA-N chloroform;methanol;hydrate Chemical compound O.OC.ClC(Cl)Cl SIHHLZPXQLFPMC-UHFFFAOYSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002481 ethanol extraction Methods 0.000 description 1
- ROAYSRAUMPWBQX-UHFFFAOYSA-N ethanol;sulfuric acid Chemical compound CCO.OS(O)(=O)=O ROAYSRAUMPWBQX-UHFFFAOYSA-N 0.000 description 1
- XYIBRDXRRQCHLP-UHFFFAOYSA-N ethyl acetoacetate Chemical compound CCOC(=O)CC(C)=O XYIBRDXRRQCHLP-UHFFFAOYSA-N 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 206010016766 flatulence Diseases 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000003292 glue Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 230000003676 hair loss Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000007442 rickets Diseases 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/90—Plate chromatography, e.g. thin layer or paper chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses the detection method of a kind of ERPIXING KELI, described drug main to be prepared from by Fructus Crataegi, Fructus Hordei Germinatus, Endothelium Corneum Gigeriae Galli, Rhizoma Dioscoreae, Semen Coicis, Semen Lablab Album, Pericarpium Citri Reticulatae and Poria, and described detection method includes discrimination method and content assaying method;Described discrimination method includes that the thin layer to Fructus Crataegi, Pericarpium Citri Reticulatae, Rhizoma Dioscoreae or Endothelium Corneum Gigeriae Galli differentiates detection;Described content assaying method includes the assay to Hesperidin or citric acid.Described detection method is accurate, and highly sensitive, reproducible, testing result is stable, can effectively detect the quality of ERPIXING KELI, and each detection standard can guarantee that curative effect of medication.
Description
Technical field
The present invention relates to the detection method of a kind of ERPIXING KELI, belong to the field of medicine technology;
Background technology
Infantile anorexia is the most common in child, and main symptom has vomiting, inappetence, diarrhoea, constipation, abdominal distention, abdomen
Pain and have blood in stool.Children anorexia is the common of department of pediatrics and frequently-occurring disease, if effective prevention can not cause infant hypoevolutism, causes battalion
Nourish one's nature anemia, rickets, give infant physical and mental health and cause increasing impact.There is Gastric gysrhythmia in anorexia child simultaneously.
The cause of disease of infantile anorexia is varied, is summed up and mainly has systemic disease, medicine, weather, emotional factor
And improper feeding and anorexia nervosa, no matter the infantile anorexia which kind of reason causes, the persistent period is longer all can affect little
Youngster's height, the normal growth of body weight, merging is become thin, malnutrition, hypoimmunity, the most then develop into infantile malnutrition sick, show as yellowish complexion
Leanness, hypotrichosis, abdominal flatulence blue veins expose or abdomen is recessed such as boat etc., have a strong impact on the growth promoter of children's, and easily initiation is also
Send out disease.Western medicine because of often cause allergy, feel sick, the toxic and side effects such as diarrhoea, liver function injury is the most increasingly avoided for people as far as possible,
Treatment infantile anorexia first-selection Chinese medicine, when the traditional Chinese medical science tackles this type of disease, often can use effect substantially and untoward reaction is less
Medicine.Medicine tool with the ERPIXING KELI that Fructus Crataegi, Fructus Hordei Germinatus, Endothelium Corneum Gigeriae Galli, Rhizoma Dioscoreae, Semen Coicis, Semen Lablab Album, Pericarpium Citri Reticulatae and Poria are made
There is invigorating the spleen and regulating the stomach, effect of promoting digestion and removing stagnation.Can be used for the infantile anorexia that insufficiency of the spleen dyspepsia causes, loose stool, weak disease such as grade of becoming thin.
In order to better control over the quality of this product, it is ensured that clinical drug effect, the invention provides the detection method of this medicine.
Summary of the invention
It is an object of the invention to, it is provided that the detection method of a kind of ERPIXING KELI;Described detection method is accurate, sensitivity
Height, reproducible, reliable results, can effectively control the quality of this product, it is ensured that the clinical drug effect of medicine.
For solving above-mentioned technical problem, the present invention adopts the following technical scheme that realization:
The detection method of a kind of ERPIXING KELI, described granule is mainly by the Fructus Crataegi 300-340 part calculated by weight, wheat
Bud
300-340 part, Endothelium Corneum Gigeriae Galli 220-260 part, Rhizoma Dioscoreae 220-260 part, Semen Coicis 140-180 part, Semen Lablab Album 220-260
Part, Pericarpium Citri Reticulatae 86-106 part and Poria 86-106 part are made as follows: above eight tastes, and Fructus Crataegi, tangerine peel powder are broken into coarse powder, use
65% ethanol as solvent, after impregnating 24 hours, carries out percolation, collects liquid of filtering, diacolation liquid recycling ethanol, be concentrated into 55-65 DEG C of phase
It is the thick paste of 1.35-1.40 to density, standby;The Six-element medical material boilings such as remaining Fructus Hordei Germinatus three times, each 1 hour, merge and decoct
Liquid, filters, and when filtrate is concentrated into 55-65 DEG C, relative density is the clear paste of 1.10, adds equivalent ethanol and makes precipitation, takes supernatant, returns
Receive ethanol, be concentrated into the thick paste that relative density is 1.35-1.40;With above-mentioned Fructus Crataegi, the mixing of Pericarpium Citri Reticulatae thick paste, add sucrose in right amount,
Make granule, be dried, to obtain final product;Described detection method includes discrimination method and content assaying method;It is right that described discrimination method includes
The thin layer of Fructus Crataegi, Pericarpium Citri Reticulatae, Rhizoma Dioscoreae or Endothelium Corneum Gigeriae Galli differentiates detection;Described content assaying method includes containing Hesperidin or citric acid
It is fixed to measure.
The detection method of aforesaid ERPIXING KELI, the discrimination method of described Fructus Crataegi is: composition granule of getting it filled, finely ground after, take
4-12g adds 20-30ml ether, is heated to reflux 0.5-1.5 hour, filters, and filtrate volatilizes, and residue adds methanol 0.5-1.5m1 to be made molten
Solve, as need testing solution;Separately take Fructus Crataegi control medicinal material 0.1-0.3g, finely ground after, take 4-12g and add 20-30ml ether, heat back
Flowing 0.5-1.5 hour, filter, filtrate volatilizes, and residue adds methanol 0.5-1.5m1 makes dissolving, prepares control medicinal material solution;Take Bears again
Fruit acid reference substance is appropriate, adds methanol and makes every 0.5-1.5ml solution containing 0.05-0.15mg, as reference substance solution;According to
State's pharmacopeia thin layer chromatography test, draws above-mentioned three all solution each 5-10 μ l, puts respectively on same silica gel g thin-layer plate, with
Toluene: ethyl acetate: formic acid=15-25: 2-6: 0.1-1.0 is developing solvent, launches, and takes out, dries, spray molten with sulphuric acid ethanol
Liquid, in ethanol solution of sulfuric acid, sulphuric acid is 2-4:9-11 with the volume ratio of ethanol;It is heated to spot development clear, respectively at 105 DEG C
Put and inspect under daylight or 360-370nm ultra-violet lamp, in test sample chromatograph, on position corresponding with control medicinal material chromatograph, aobvious
The principal spot of same color or fluorescence principal spot;On position corresponding with reference substance chromatograph, the speckle or glimmering of aobvious same color
Light speckle.
The detection method of aforesaid ERPIXING KELI, the discrimination method of described Fructus Crataegi is: composition granule of getting it filled, finely ground after, take
8g adds 25ml ether, is heated to reflux 1 hour, filters, and filtrate volatilizes, and residue adds methanol 1m1 makes dissolving, as need testing solution;
Separately take Fructus Crataegi control medicinal material 0.2g, finely ground after, take 8g and add 25ml ether, be heated to reflux 1 hour, filter, filtrate volatilizes, and residue adds
Methanol 1m1 makes dissolving, prepares control medicinal material solution;Take ursolic acid reference substance more appropriate, add methanol and make every 1ml containing 0.1mg's
Solution, as reference substance solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above-mentioned three all solution each 5~10 μ l, point
Other point is on same silica gel g thin-layer plate, with toluene: ethyl acetate: formic acid=20: 4: 0.5 as developing solvent, launches, and takes out, dries in the air
Dry, spray with ethanol solution of sulfuric acid, in ethanol solution of sulfuric acid, sulphuric acid is 3:10 with the volume ratio of ethanol;It is heated to speckle at 105 DEG C
Colour developing is clear, puts respectively and inspects under daylight or 365nm ultra-violet lamp, in test sample chromatograph, corresponding with control medicinal material chromatograph
On position, the principal spot of aobvious same color or fluorescence principal spot;On position corresponding with reference substance chromatograph, aobvious same color
Speckle or fluorescence speckle.
The detection method of aforesaid ERPIXING KELI, the discrimination method of described Pericarpium Citri Reticulatae is: composition granule of getting it filled, finely ground after, take
5-15g, adds methanol 25-35ml, is heated to reflux 0.5-1.5 hour, filters, and filtrate volatilizes, and the residue 5-15ml that adds water makes dissolving, turns
Moving in separatory funnel, extract 2-3 time with ethyl acetate shaking, each each 5-15ml, combined ethyl acetate extracting solution, in water-bath
Being evaporated, residue adds methanol 1-4ml makes dissolving, as need testing solution;Separately taking Pericarpium Citri Reticulatae control medicinal material 0.5-1.5g, it is right to be made in the same way of
According to medical material solution;Take Hesperidin reference substance more appropriate, add methanol and make saturated solution, as reference substance solution;According to middle traditional Chinese medicines
Allusion quotation thin layer chromatography is tested, and draws above-mentioned three kinds of solution each 2-5 μ l, puts respectively in same 0.1-1.0% sodium hydroxide solution
On the silica gel g thin-layer plate of preparation, with ethyl acetate: methanol: water=95-105: 15-19: 10-16, as developing solvent, opens up to 1-6cm,
Take out, dry, then with toluene: ethyl acetate: formic acid: the upper solution of water=15-25: 5-15: 0.5-1.5: 0.5-1.5 is for exhibition
Opening agent, open up to 5-10cm, take out, dry, spray is with 1-10% aluminum chloride ethanol solution, and being placed in wavelength is 360-370nm ultraviolet
Inspect under light modulation;In test sample chromatograph, on position corresponding with control medicinal material chromatograph, the fluorescence principal spot of aobvious same color;
On position corresponding with reference substance chromatograph, the fluorescence speckle of aobvious same color.
The detection method of aforesaid ERPIXING KELI, the discrimination method of described Endothelium Corneum Gigeriae Galli is: composition granule of getting it filled, finely ground, takes
1-10g, add water 25-35ml, steeped overnight, and aqueous solution, together with in residue dislocation separatory funnel, adds water saturated n-butyl alcohol
Shaking is extracted 2-4 time, each 15-25ml, divides and takes n-butyl alcohol liquid, is evaporated, and residue adds proper amount of methanol makes dissolving, is added on 100-120
Mesh, 1-10g, internal diameter 10-15mm neutral alumina column on, with 5-15% methanol 90-110ml eluting, collect eluent, steam
Dry, residue adds 0.5-1.5ml, 65-75% ethanol makes dissolving, as need testing solution;Separately take Endothelium Corneum Gigeriae Galli control medicinal material 0.5-
1.5g, add water 25-35ml, decocts 1-3 hour, and aqueous solution, together with in residue dislocation separatory funnel, is made in the same way of comparison medicine
Material solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above two solution each 3~5 μ l, put respectively in same silica gel G
On lamellae, with n-butyl alcohol: glacial acetic acid: water=5-15: 1-6: the 0.5-1.5 lamellae 10-as developing solvent, after pre-equilibration point sample
20 minutes, launching, take out, dry, spray, with ninhydrin solution, is heated to spot development at 110 DEG C clear;In test sample chromatograph,
On position corresponding with control medicinal material chromatograph, the principal spot of aobvious same color.
The detection method of aforesaid ERPIXING KELI, the discrimination method of described Endothelium Corneum Gigeriae Galli is: composition granule of getting it filled, finely ground, takes
5g, add water 30ml, steeped overnight, and aqueous solution, together with in residue dislocation separatory funnel, adds the shaking of water saturated n-butyl alcohol and carries
Taking 3 times, each 20ml, divide and take n-butyl alcohol liquid, be evaporated, residue adds proper amount of methanol makes dissolving, is added on 100-120 mesh, 5g, internal diameter
On the neutral alumina column of 10-15mm, with 10% methanol 100ml eluting, collecting eluent, be evaporated, residue adds 1ml70% ethanol
Make dissolving, as need testing solution;Separately taking Endothelium Corneum Gigeriae Galli control medicinal material 1g, add water 30ml, decocts 2 hours, and aqueous solution is together with residue
Together in dislocation separatory funnel, it is made in the same way of control medicinal material solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above-mentioned two
Plant solution each 3~5 μ l, put respectively on same silica gel g thin-layer plate, with n-butyl alcohol: glacial acetic acid: water=9: 3: 1 as developing solvent, in advance
Lamellae after balance point sample 15 minutes, launches, and takes out, dries, and spray, with ninhydrin solution, is heated to spot development at 110 DEG C
Clearly;In test sample chromatograph, on position corresponding with control medicinal material chromatograph, the principal spot of aobvious same color.
The detection method of aforesaid ERPIXING KELI, described content of hesperidin assay method is:
According to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica as filler;With methanol: ice vinegar
Acid: water=30-40: 1-8: 55-65 is flowing phase;Column temperature is 33-37 DEG C;Detection wavelength is 280-286nm;Number of theoretical plate is by orange
Skin glycosides peak calculates should be not less than 3000;
The preparation of reference substance solution: take Hesperidin reference substance appropriate, accurately weighed, add methanol and make every 0.5-1.5ml and contain
The solution of 0.005-0.015mg, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, mixing, finely ground, take 0.2-0.6g, accurately weighed, put tool
In plug conical flask, accurate addition methanol 20-30ml, close plug, weighed weight, supersound process, sonification power is 200-300W,
Supersound process frequency is 30-40kHz, and sonication treatment time is 25-35 minute, lets cool, more weighed weight, supplies less loss with methanol
Weight, shake up, filter, take subsequent filtrate, to obtain final product;
Algoscopy: precision draws reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures,
Obtain.
The detection method of aforesaid ERPIXING KELI, described content of hesperidin assay method is:
According to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica as filler;With methanol: ice vinegar
Acid: water=35: be flowing phase at 4: 61;Column temperature is 35 DEG C;Detection wavelength is 283nm;Number of theoretical plate presses the calculating of Hesperidin peak should not
Less than 3000;
The preparation of reference substance solution: take Hesperidin reference substance appropriate, accurately weighed, add methanol and make every 1ml containing 0.01mg
Solution, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, mixing, finely ground, take 0.4g, accurately weighed, put tool plug cone
In shape bottle, accurate addition methanol 25ml, close plug, weighed weight, supersound process, sonification power is 250W, supersound process frequency
Rate is 35kHz, and sonication treatment time is 30 minutes, lets cool, more weighed weight, supplies the weight of less loss with methanol, shakes up, filter
Cross, take subsequent filtrate, to obtain final product;
Algoscopy: precision draws reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures,
Obtain.
The detection method of aforesaid ERPIXING KELI, described citric acid content assaying method is: efficient according to Chinese Pharmacopoeia
Liquid chromatography for measuring:
Chromatographic condition and system suitability: be filler with octadecylsilane chemically bonded silica;Number of theoretical plate presses Chinese holly
Rafter acid peak calculates should be not less than 3000;
The preparation of reference substance solution: take citric acid reference substance appropriate, accurately weighed, add water and make every 0.5-1.5ml and contain
The solution of 0.1-0.6mg, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, finely ground, precision weighs 1-4g, puts in 20-30ml measuring bottle,
The accurate water that adds is appropriate, and supersound process, sonification power is 200-300W, and supersound process frequency is 30-40kHz, ultrasonic place
The reason time is 15-25 minute, lets cool, and is diluted with water to scale and shakes up, and filters, and takes subsequent filtrate, crosses the filter of 0.35-0.55 μm micropore
Film, to obtain final product.
Algoscopy: precision draws reference substance solution and need testing solution each 15-25 μ l respectively, injects chromatograph of liquid, surveys
Fixed, to obtain final product.
The detection method of aforesaid ERPIXING KELI, the discrimination method of described Fructus Crataegi is: after composition granule of getting it filled is finely ground, take 8g
Adding 25ml ether, be heated to reflux 1 hour, filter, filtrate volatilizes, and residue adds methanol 1m1 makes dissolving, as need testing solution;Separately
Take Fructus Crataegi control medicinal material 0.2g, finely ground after, take 8g and add 25ml ether, be heated to reflux 1 hour, filter, filtrate volatilizes, and residue adds first
Alcohol 1m1 makes dissolving, prepares control medicinal material solution;Take ursolic acid reference substance more appropriate, add methanol and make molten containing 0.1mg of every 1ml
Liquid, as reference substance solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above-mentioned three all solution each 5~10 μ l, respectively
Point is on same silica gel g thin-layer plate, with toluene: ethyl acetate: formic acid=20: 4: 0.5 as developing solvent, launches, takes out, dry,
Spraying with ethanol solution of sulfuric acid, in ethanol solution of sulfuric acid, sulphuric acid is 3:10 with the volume ratio of ethanol;It is heated to spot development at 105 DEG C
Clearly, put respectively and inspect under daylight or 365nm ultra-violet lamp, in test sample chromatograph, in position corresponding with control medicinal material chromatograph
On, the principal spot of aobvious same color or fluorescence principal spot;On position corresponding with reference substance chromatograph, the speckle of aobvious same color
Or fluorescence speckle;
The discrimination method of described Pericarpium Citri Reticulatae is: composition granule content of getting it filled, finely ground after, take 10g, add methanol 30ml, heat back
Flowing 1 hour, filter, filtrate volatilizes, and the residue 10ml that adds water makes dissolving, is transferred in separatory funnel, shakes extraction 2 by ethyl acetate
Secondary, each each 10ml, combined ethyl acetate extracting solution, water-bath is evaporated, residue adds methanol 2ml makes dissolving, molten as test sample
Liquid;Separately take Pericarpium Citri Reticulatae control medicinal material 1g, be made in the same way of control medicinal material solution;Take Hesperidin reference substance more appropriate, add methanol and make full
And solution, as reference substance solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above-mentioned three kinds of solution each 2~5 μ l, point
Other point is on the same silica gel g thin-layer plate prepared with 0.5% sodium hydroxide solution, with ethyl acetate: methanol: water=100: 17:
13 is developing solvent, opens up to about 3cm, takes out, dry, then with toluene: ethyl acetate: formic acid: water=20: the upper solution of 10: 1: 1
For developing solvent, opening up to 8cm, take out, dry, spray is with 5% aluminum chloride ethanol solution, and being placed in wavelength is under 365nm ultra-violet lamp
Inspect;In test sample chromatograph, on position corresponding with control medicinal material chromatograph, the fluorescence principal spot of aobvious same color;With right
According on the corresponding position of product chromatograph, show the fluorescence speckle of same color;
The discrimination method of described Endothelium Corneum Gigeriae Galli is: composition granule of getting it filled, finely ground, takes 5g, and add water 30ml, steeped overnight, aqueous solution
Together with in residue dislocation separatory funnel, add the shaking of water saturated n-butyl alcohol and extract 3 times, each 20ml, divide and take n-butyl alcohol liquid,
Being evaporated, residue adds proper amount of methanol makes dissolving, is added on the neutral alumina column of 100-120 mesh, 5g, internal diameter 10-15mm, with 10%
Methanol 100ml eluting, collects eluent, is evaporated, and residue adds 1ml70% ethanol makes dissolving, as need testing solution;Separately take in chicken
Gold control medicinal material 1g, add water 30ml, decocts 2 hours, and aqueous solution, together with in residue dislocation separatory funnel, is made in the same way of comparison
Medical material solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above two solution each 3~5 μ l, put respectively in same silica gel
On G lamellae, with n-butyl alcohol: glacial acetic acid: water=9: 3: 1 as developing solvent, the lamellae after pre-equilibration point sample 15 minutes, launch,
Taking out, dry, spray, with ninhydrin solution, is heated to spot development at 110 DEG C clear;In test sample chromatograph, with control medicinal material
On the corresponding position of chromatograph, the principal spot of aobvious same color;
Described content of hesperidin assay method is: according to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica as filler;With methanol: ice vinegar
Acid: water=35: be flowing phase at 4: 61;Column temperature is 35 DEG C;Detection wavelength is 283nm;Number of theoretical plate presses the calculating of Hesperidin peak should not
Less than 3000;
The preparation of reference substance solution: take Hesperidin reference substance appropriate, accurately weighed, add methanol and make every 1ml containing 0.01mg
Solution, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, mixing, finely ground, take 0.4g, accurately weighed, put tool plug cone
In shape bottle, accurate addition methanol 25ml, close plug, weighed weight, supersound process, sonification power is 250W, supersound process frequency
Rate is 35kHz, and sonication treatment time is 30 minutes, lets cool, more weighed weight, supplies the weight of less loss with methanol, shakes up, filter
Cross, take subsequent filtrate, to obtain final product;
Algoscopy: precision draws reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures,
Obtain;Described citric acid content assaying method is: according to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: be filler with octadecylsilane chemically bonded silica;With 5% biphosphate
Ammonium salt solution, is flowing phase with phosphoric acid slow-readjustment joint pH to 3.0, and column temperature is 25 DEG C;Detection wavelength is 210nm;Number of theoretical plate presses citron
Acid peak calculates and should be not less than 3000;
The preparation of reference substance solution: take citric acid reference substance appropriate, accurately weighed, add water and make molten containing 0.3mg of every 1ml
Liquid, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, finely ground, precision weighs 2.0g, puts in 25ml measuring bottle, accurate
Adding water appropriate, supersound process, sonification power is 250W, and supersound process frequency is 35kHz, and sonication treatment time is 20 points
Clock, lets cool, and is diluted with water to scale and shakes up, and filters, and takes subsequent filtrate, crosses 0.45 μm microporous filter membrane, to obtain final product.
Algoscopy: precision draws reference substance solution and each 20 μ l of need testing solution respectively, injects chromatograph of liquid, measures,
Obtain.
Inventor has carried out substantial amounts of experiment, the following is the research of detection method of the present invention
Experimental example: detection method research
One, sample
Sample: ERPIXING KELI, is prepared as described in Example 1, for the granule of brown color;Feeble QI is fragrant, sweet and sour,
Micro-hardship.Recording in WS-10441 (ZD-0441)-2002-2012Z, in standard, original project is: character;Fructus Crataegi, Pericarpium Citri Reticulatae thin layer mirror
Not;Check;Assay project is the mensuration of Hesperidin in Pericarpium Citri Reticulatae;According to improving quality criteria requirements, intend primary standard project
Carry out revising and Rhizoma Dioscoreae, the discriminating of Endothelium Corneum Gigeriae Galli thin layer, Fructus Crataegi assay in the side of adding.Through experimentation to this product quality standard
Propose to increase revision project and carried out Method validation, increase revision checking Description Experimental according to as follows.
Two, differentiate
1, the thin layer of Fructus Crataegi differentiates:
Primary standard is recorded and is only used ursolic acid as comparison in method, and specificity is strong, therefore here, is repaiied this discriminating
Order, add Fructus Crataegi comparison material.Revision method is: take the content under this product content uniformity item, finely ground, takes about 8g, adds diethyl ether
25ml, is heated to reflux 1 hour, filters, and filtrate volatilizes, and residue adds methanol 1m1 makes dissolving, as need testing solution.Separately take Fructus Crataegi
Control medicinal material 0.2g, obtains control medicinal material solution with legal system.Take ursolic acid reference substance more appropriate, add methanol and make every 1ml containing 0.1mg
Solution, as reference substance solution.Test according to thin layer chromatography (Chinese Pharmacopoeia four general rules 0502 of version in 2015), draw above-mentioned
Three all solution each 5~10 μ l, put on same silica gel g thin-layer plate, respectively with toluene-ethyl acetate-formic acid (20: 4: 0.5)
For developing solvent, launching, take out, dry, spray, with ethanol solution of sulfuric acid (3 → 10), is heated to spot development at 105 DEG C clear.Point
Do not put and inspect under daylight or ultra-violet lamp (365nm), in test sample chromatograph, on position corresponding with control medicinal material chromatograph, aobvious
The principal spot of same color or fluorescence principal spot;On position corresponding with reference substance chromatograph, the speckle or glimmering of aobvious same color
Light speckle.On request, this discriminating is carried out methodological study, through Method validation, this thin-layer identification method clear spot,
Separator well, reappears, and negative noiseless.Method validation is as follows:
1.1 reagent and reagent
ERPIXING KELI is provided by Guizhou Run Sheng pharmacy industry company limited, is i.e. prepared by embodiment 1;Fructus Crataegi comparison medicine
Material (121626-201402), ursolic acid reference substance (110742-201421) are provided by Nat'l Pharmaceutical & Biological Products Control Institute;
Silica gel g thin-layer plate: the silica gel g thin-layer plate of subsidiary factory of Haiyang Chemical Plant, Qingdao production and self-control silica gel g thin-layer plate;Reagent: toluene, second
Acetoacetic ester, formic acid are analytical pure;
1.2 specificity
Take ERPIXING KELI, Fructus Crataegi control medicinal material, ursolic acid reference substance and scarce Fructus Crataegi negative sample, with method described in text
Prepare need testing solution, control medicinal material solution, reference substance solution and negative need testing solution, respectively point sample, launch, develop the color, put
Daylight or ultra-violet lamp (365nm), in test sample chromatograph, on position corresponding with control medicinal material chromatograph, aobvious same color
Principal spot or fluorescence principal spot;On position corresponding with reference substance chromatograph, the speckle of aobvious same color or fluorescence speckle.And speckle
Point separates preferably, negative noiseless, is specifically shown in Fig. 1 and Fig. 2.
2, Pericarpium Citri Reticulatae thin layer differentiates
After recording method extraction point sample due to primary standard, sample impurity is more, has certain interference, differentiates to extract to this at this
The further remove impurity of method, adds reference substance point sample simultaneously, and method is defined as: takes the content under this product content uniformity item, grinds
Carefully, taking about 10g, add methanol 30ml, be heated to reflux 1 hour, filter, filtrate volatilizes, and the residue 10ml that adds water makes dissolving, is transferred to point
In liquid funnel, extract 2 times with ethyl acetate shaking, each each 10ml, combined ethyl acetate extracting solution, water-bath is evaporated, residue
Add methanol 2ml and make dissolving, as need testing solution.Separately take Pericarpium Citri Reticulatae control medicinal material 1g, be made in the same way of control medicinal material solution.Take orange again
Skin glycosides reference substance is appropriate, adds methanol and makes saturated solution, as reference substance solution.According to thin layer chromatography (Chinese Pharmacopoeia 2015
Four general rules 0502 of version) test, draw above-mentioned three kinds of solution each 2~5 μ l, put respectively and use 0.5% sodium hydroxide solution in same
On the silica gel g thin-layer plate of preparation, with acetate-methanol-water 100: 17: 13) as developing solvent, open up to about 3cm, take out, dry,
Again with the upper solution of toluene-ethyl acetate-formic acid-water (20: 10: 1: 1) as developing solvent, open up to about 8cm, take out, dry, spray
With 5% aluminum chloride ethanol solution, put and inspect under ultra-violet lamp (365nm).In test sample chromatograph, with control medicinal material chromatograph phase
On the position answered, the fluorescence principal spot of aobvious same color;On position corresponding with reference substance chromatograph, the fluorescence of aobvious same color
Speckle.This discriminating has been carried out methodological study, through Method validation, this thin-layer identification method clear spot, separator well, weight
The best and negative noiseless.Method validation is as follows:
2.1 reagent and reagent
ERPIXING KELI is provided by Guizhou Run Sheng pharmacy industry company limited;Pericarpium Citri Reticulatae control medicinal material (120969-201109) and
Hesperidin reference substance (110721-201014) is provided by Nat'l Pharmaceutical & Biological Products Control Institute;Lamellae: Qingdao Haiyang chemical industry
The silica gel g thin-layer plate that subsidiary factory of factory produces immerses 0.5% sodium hydroxide solution, takes out, dries;Make 0.5% sodium hydroxide solution by oneself
The silica gel g thin-layer plate of preparation;Reagent: toluene, ethyl acetate, formic acid, methanol are analytical pure;
2.2, specificity
Take ERPIXING KELI, Pericarpium Citri Reticulatae control medicinal material, Hesperidin reference substance and scarce Pericarpium Citri Reticulatae negative sample, with method described in text
Prepare need testing solution, control medicinal material solution, reference substance solution and negative need testing solution, respectively point sample, launch, develop the color, put
Inspecting under ultra-violet lamp (365nm), in test sample chromatograph, on position corresponding with control medicinal material chromatograph, aobvious same color is glimmering
Light principal spot, on position corresponding with reference substance chromatograph, the fluorescence speckle of aobvious same color.And speckle separates preferably, negative
Noiseless, see Fig. 3.
2.3 Rhizoma Dioscoreae thin layers differentiate
Through overtesting, method is defined as: composition granule of getting it filled, finely ground, takes about 5g, and add methylene chloride 50ml, is heated to reflux 2 little
Time, filtering, take filtrate and put in separatory funnel, wash with water 3 times, each 50ml, divide and take dichloromethane solution, be evaporated, residue adds 1ml
Dichloromethane makes dissolving, as need testing solution.Separately take Rhizoma Dioscoreae control medicinal material 0.5g, be made in the same way of control medicinal material solution.According to thin
Layer chromatography (Chinese Pharmacopoeia four general rules 0502 of version in 2015) test, draw above two solution each 5~10 μ l, put respectively in
Lamellae 15 on same silica gel g thin-layer plate, with chloroform-methanol-water (16: 3: 0.1) as developing solvent, after pre-equilibration point sample
Minute, launching, take out, dry, spray, with phosphomolybdic acid test solution, is heated to spot development at 110 DEG C clear.In test sample chromatograph,
On position corresponding with control medicinal material chromatograph, the principal spot of aobvious same color.By pharmacopoeial requirements, this discriminating is carried out methodology
Investigate, through Method validation, this thin-layer identification method clear spot, separator well, reappear, and negative noiseless.Methodology
Verify as follows:
2.3.1, reagent and reagent
ERPIXING KELI Guizhou Run Sheng pharmacy industry company limited provides;Rhizoma Dioscoreae control medicinal material (121137-200402) by
State's medicine biological products assay institute provides;Silica gel thin-layer plate: the silica gel g thin-layer plate of subsidiary factory of Haiyang Chemical Plant, Qingdao production and self-control
Silica gel g thin-layer plate reagent: dichloromethane, chloroform, methanol are analytical pure, water is super purified water;
2.3.2, specificity
Take ERPIXING KELI, Rhizoma Dioscoreae control medicinal material and scarce Rhizoma Dioscoreae negative sample, prepare test sample with method described in text molten
Liquid, control medicinal material solution, reference substance solution and negative need testing solution, respectively point sample, launch, spray with phosphomolybdic acid test solution, 110
DEG C it is heated to spot development clear, in test sample chromatograph, the master of aobvious same color on position corresponding with control medicinal material chromatograph
Speckle, and speckle separation is preferably, negative noiseless, result is shown in Fig. 4.
The thin layer of 2.4 Endothelium Corneum Gigeriae Galli differentiates
Through overtesting, method is defined as: composition granule of getting it filled, finely ground, takes about 5g, and add water 30ml, steeped overnight, and aqueous solution is even
With in residue together dislocation separatory funnel, add the shaking of water saturated n-butyl alcohol and extract 3 times, each 20ml, divides and takes n-butyl alcohol liquid, steam
Dry, residue adds proper amount of methanol makes dissolving, is added on neutral alumina column (100-120 mesh, 5g, internal diameter 10-15mm), uses 10% first
Alcohol 100ml eluting, collects eluent, is evaporated, and residue adds 1ml70% ethanol makes dissolving, as need testing solution.Separately take Endothelium Corneum Gigeriae Galli
Control medicinal material 1g, add water 30ml, decocts 2 hours, and aqueous solution, together with in residue dislocation separatory funnel, is made in the same way of comparison medicine
Material solution.Test according to thin layer chromatography (Chinese Pharmacopoeia four general rules 0502 of version in 2015), draw above two solution each 3~5 μ
L, puts respectively on same silica gel g thin-layer plate, with n-butyl alcohol-glacial acetic acid-water (9:3:1) as developing solvent, after pre-equilibration point sample
Lamellae 15 minutes, launches, and takes out, dries, and spray, with ninhydrin solution, is heated to spot development at 110 DEG C clear.Test sample color
In spectrum, on position corresponding with control medicinal material chromatograph, the speckle of aobvious same color.By pharmacopoeial requirements, this discriminating is carried out
Methodological study, through Method validation, this thin-layer identification method clear spot, separator well, reappear, and negative noiseless.
Method validation is as follows:
2.4.1 reagent and reagent
ERPIXING KELI is provided by Guizhou Run Sheng pharmacy industry company limited;Endothelium Corneum Gigeriae Galli control medicinal material (1153-200001) by
Nat'l Pharmaceutical & Biological Products Control Institute provides;Silica gel g thin-layer plate: subsidiary factory of Haiyang Chemical Plant, Qingdao produce silica gel g thin-layer plate and
Self-control silica gel g thin-layer plate;Reagent: methanol, ethanol, n-butyl alcohol are analytical pure, water is super purified water;
2.4.2 specificity
Take ERPIXING KELI, Endothelium Corneum Gigeriae Galli control medicinal material and scarce Endothelium Corneum Gigeriae Galli negative sample, prepare for examination with method described in text
Product solution, control medicinal material solution, reference substance solution and negative need testing solution, respectively point sample, launch, spray with ninhydrin solution,
It is heated to spot development clear at 110 DEG C, in test sample chromatograph, aobvious same color on position corresponding with control medicinal material chromatograph
Principal spot, and speckle separates preferably, negative noiseless, sees Fig. 5.
Two, assay
1 content of hesperidin measures
Pericarpium Citri Reticulatae: Pericarpium Citri Reticulatae assay, for record for primary standard, there is no revision, as requested, records primary standard old at this
Skin assay has carried out Method validation, and Method validation is as follows:
1.1 instrument and reagent
High performance liquid chromatograph: Shimadzu chromatograph of liquid;ERPIXING KELI: Guizhou Runsheng Pharmaceutical Co., Ltd.;Hesperidin
Reference substance is provided by Nat'l Pharmaceutical & Biological Products Control Institute, and lot number is 110721-201014;Reagent: methanol is that chromatograph alcohol, water are
Double distilled water.
1.2 assay method
1.2.1 chromatography condition:
(1) chromatographic column: with reference to primary standard and version pharmacopeia Pericarpium Citri Reticulatae assay in 2010, selects octadecylsilane bonded silica
Glue is that the pillar of filler is investigated.Result shows that the pillar using octadecylsilane chemically bonded silica to be filler separates effect
Fruit is preferably.
(2) flowing phase: with reference to primary standard, uses methanol-glacial acetic acid-water (35: 4: 61) for flowing phase, composition Pericarpium Citri junoris to be measured
Glycosides and the available preferably separation of other impurity.
(3) detection wavelength: measuring with reference to primary standard and version pharmacopeia content of hesperidin in 2010, detection wavelength is set to 283nm.
(4) theoretical cam curve: according to different pillar testing results, referring concurrently to version pharmacopeia Pericarpium Citri Reticulatae assay in 2010,
Tentative theoretical cam curve is pressed Hesperidin peak and is calculated, and should be not less than 3000.
1.2.2 the preparation of need testing solution
Get it filled composition granule, mixing, finely ground, take about 0.4g, accurately weighed, put in tool plug conical flask, accurate add methanol
25ml, close plug, weighed weight, supersound process (power 250W, frequency 35kHz) 30 minutes, let cool, more weighed weight, use methanol
Supply less loss weight, shake up, filter, take subsequent filtrate, to obtain final product.
1.2.3, the preparation of reference substance solution
Take Hesperidin reference substance appropriate, accurately weighed, add methanol and make every 1ml solution containing 0.01mg, to obtain final product.
1.3 method validation
The most linearly investigate
Precision absorption Hesperidin reference substance solution (0.031906mg/ml) 1ml, 2ml, 3ml, 5ml, 6ml, 10ml arrive respectively
In 10ml volumetric flask, add methanol to scale, point take 10 μ l sample introductions, record chromatograph, with peak area as vertical coordinate, with sample size (μ g)
Mapping for abscissa, calculating regression equation is: A=1847322.47C+3897.83801 (r=0.9999), regression equation matching
The linear equation crossing initial point is: A=1866179.663C;See that Fig. 6 and Biao 1. is by a need testing solution sample introduction analysis, face, gained peak
Integration does not substitute into two formulas and calculates, and relative deviation is 0.32%, therefore it is believed that standard curve crosses initial point, regression equation intercept is
Zero.Thus assay can use one point external standard method to calculate.Hesperidin linear relationship between 0.032 μ g~0.319 μ g is good.
Table 1 Hesperidin linear relationship is investigated
1.3.2, precision test
Take reference substance solution 0.011867mg/ml, repeat sample introduction 6 times, record chromatograph, the results are shown in Table 2 and precision collection of illustrative plates,
RSD is 0.41%, and good precision is described.
Table 2 precision test
1.3.3, replica test
Take a sample as described in text, prepare 6 parts of need testing solutions, respectively sample introduction, record chromatograph, calculate, the results are shown in Table 3,
Repeatability collection of illustrative plates, RSD is 0.58%, and good repeatability is described.
Table 3 replica test
1.3.4, recovery test
Using sample-adding to reclaim, accurate absorption has measured the sample 0.2g (0.5789mg/g) of content, adds Hesperidin pair
Appropriate according to product, as described in text, chromatographic condition measures, and calculates the response rate, the results are shown in Table 4, response rate collection of illustrative plates, the recovery of Hesperidin
Rate is 97.81%, and RSD is 0.75%, illustrates that this law has the good response rate.
Table 4 recovery test
1.3.5, specificity
Take ERPIXING KELI and negative sample and prepare sample solution and negative sample solution by need testing solution preparation method,
By above-mentioned chromatographic condition, take reference substance solution, sample solution, negative sample solution injection chromatograph of liquid, sample solution respectively
Chromatograph is equipped with corresponding chromatographic peak in reference substance solution chromatograph corresponding positions, and negative noiseless, and result is shown in Fig. 8, Fig. 9 and Figure 10.
1.3.6, ruggedness
1.3.6.1 the selection of sample extraction solvent
Get it filled composition granule, finely ground, take 5 parts, every part of about 0.4g, accurately weighed, put in tool plug conical flask, precision adds respectively
Ethanol, methanol, 60% methanol, 70% methanol, the 80% each 25ml of methanol, weighed weight, supersound process 30 minutes, let cool, then claim
Determine weight, supply the weight of less loss respectively with ethanol, methanol, 60% methanol, 70% methanol, 80% methanol, shake up, filter, take
Subsequent filtrate is as need testing solution.Take each 10 μ l of above-mentioned solution respectively and inject chromatograph of liquid, calculate, the results are shown in Table 5, this is described
Product use methanol to extract more complete as Extraction solvent, content.
The selection of table 5 Extraction solvent
1.3.6.2, the selection of sample extraction method
Get it filled composition granule, finely ground, take 2 parts, every part of about 0.4g, accurately weighed, to put in tool plug conical flask for the 1st part, precision adds
Enter methanol 25ml, supersound process 30 minutes, another part of reflux, extract, 30 minutes, take out, let cool, supply less loss weight with methanol,
Shake up, filter;Take above-mentioned 2 kinds of solution 10 μ l respectively and inject chromatograph of liquid, calculate, the results are shown in Table 6, reflux, extract, content, super
Sound extraction content is without essential difference, therefore selects supersound extraction.
The selection of table 6 extracting method
1.3.6.3, sample extraction time effects
Take the content drug particles under content uniformity item, finely ground, take 3 parts, every part of about 0.4g, accurately weighed, put respectively
In tool plug conical flask, the accurate methanol 25ml that adds, weighed weight, respectively supersound extraction 10,15,30,40 minutes, take out, let cool,
Supply less loss weight with methanol, shake up, filter, take 10 μ l subsequent filtrates respectively and inject chromatograph of liquid, calculate content, the results are shown in Table
7, supersound extraction is extracted for 30 minutes the most completely, therefore the selective extraction time is 30 minutes.
Table 7 extraction time affects
Extracting method is defined as: composition granule of getting it filled, mixing, finely ground, takes about 0.4g, accurately weighed, puts in tool plug conical flask,
Accurate addition methanol 25ml, close plug, weighed weight, supersound process (power 250W, frequency 35kHz) 30 minutes, let cool, more weighed
Weight, supplies less loss weight with methanol, shakes up, and filters, takes subsequent filtrate, to obtain final product.
1.3.6.4, the impact of different brands pillar
Using different brands octadecylsilane chemically bonded silica is the pillar of filler, determines respectively in ERPIXING KELI
The content of Hesperidin, investigates the impact of the chromatographic column of different brands.Assay the results are shown in Table 8.Result shows different brands ten
Eight alkyl silane bonded silica gels be filler chromatographic column on assay without impact.
The measurement result of table 8 different brands chromatographic column
1.3.6.5, sample stability test
Take ERPIXING KELI, prepare by need testing solution preparation method, measure Hesperidin peak area by above-mentioned chromatographic condition,
The results are shown in Table 9.
Table 9 sample stability is tested
1.3.7 ten batches of content sample determinations: result table 10;
Table 10 10 batch sample assay result
According to primary standard content limit and 10 batch sample measured values, this product Pericarpium Citri Reticulatae assay limit is: this product every bag contains
Pericarpium Citri Reticulatae is with Hesperidin (C28H34O15) meter, 0.62mg must not be less than.
2, Fructus Crataegi assay
2.1, instrument and reagent
Chromatograph of liquid: Waters e2695 chromatograph of liquid;ERPIXING KELI: Guizhou Runsheng Pharmaceutical Co., Ltd.;Chinese holly
Rafter acid reference substance (100396-200301) is provided by Nat'l Pharmaceutical & Biological Products Control Institute;Reagent: ammonium dihydrogen phosphate, phosphoric acid are
AG, water are super purified water.
2.2, assay method
2.2.1, chromatography condition
(1) chromatographic column: the pillar selecting octadecylsilane chemically bonded silica to be filler is investigated.Result shows to use
Octadecylsilane chemically bonded silica is that the pillar separating effect of filler is preferable.
(2) flowing phase: compare difference flowing mutually, uses 5% ammonium dihydrogen phosphate (with phosphoric acid slow-readjustment joint pH extremely
3.0) preferably separate for flowing phase, composition citric acid to be measured and other impurity are available.
(3) detection wavelength: according to the uv absorption wavelength of citric acid reference substance, detection wavelength is set to 210nm.
(4) theoretical cam curve: according to different pillar testing results, tentative theoretical cam curve is pressed citric acid and is calculated, should not be low
In 3000.
2.2.2, the preparation of need testing solution
Getting it filled composition granule, finely ground, precision weighs about 2.0g, puts in 25ml measuring bottle, and the accurate water that adds is appropriate, supersound process
(power 250W, frequency 35kHz) 20 minutes, lets cool, is diluted with water to scale, shake up, and filters, and takes subsequent filtrate, crosses 0.45 μm micro-
Hole filter membrane, to obtain final product.
2.2.3, the preparation of reference substance solution
Taking citric acid reference substance appropriate, accurately weighed, add water the solution making every 1ml containing 0.5mg, to obtain final product.
2.3, method validation
2.3.1, linear investigation precision weighs citric acid reference substance 0.2010g to 10ml measuring bottle and obtains A liquid (2.01mg/ml);
Take 1mlA liquid to 2ml measuring bottle and obtain B liquid (1.005mg/ml);Take 2mlA liquid to 5ml measuring bottle and obtain C liquid (0.804mg/ml);Take
1.5mlA liquid to 5ml measuring bottle obtains D liquid (0.603mg/ml);Take 1ml B liquid to 2ml measuring bottle and obtain E liquid (0.402mg/ml);Take 1ml
E liquid to 2ml measuring bottle obtains F liquid (0.201mg/ml);Take 1ml F liquid to 2ml measuring bottle and obtain G liquid (0.1005mg/ml), B, C, D, E, F,
G divides and takes 20 μ l sample introductions.Record chromatograph, with peak area as vertical coordinate, is abscissa mapping with sample size (μ g), calculates regression equation
For A=146399.4943C-65747.9151 (r=0.9998), regression equation matching is crossed the linear equation of initial point and is: A=
141811.156C;Being analyzed by one need testing solution sample introduction, gained peak area substitutes into two formulas respectively and calculates, and relative deviation is
3.27%, therefore it is believed that standard curve crosses initial point, regression equation no intercept.Thus assay can use one point external standard method meter
Calculate.Citric acid linear relationship between 2.02 μ g~20.1 μ g is good.Concrete outcome is shown in Table 11 and Fig. 7.
Table 11 citric acid linear relationship investigates (n=2)
2.3.2, precision test
Take same citric acid reference substance solution, repeat sample introduction 6 times, record chromatograph, the results are shown in Table 12 and precision collection of illustrative plates,
RSD is 0.19%, and good precision is described.
Table 12 precision test
2.3.3 replica test
Take a sample as described in text, prepare 6 parts of need testing solutions, respectively sample introduction, record chromatograph, calculate, the results are shown in Table
13, RSD is 1.01%, and good repeatability is described.
Table 13 replica test
2.3.4 recovery test
Using sample-adding to reclaim, accurate absorption has measured the sample 1g (4.007mg/g) of content, adds citric acid reference substance
In right amount, as described in text, chromatographic condition measures, and calculates the response rate, the results are shown in Table 14, and response rate collection of illustrative plates, the response rate of citric acid is
102.93%, RSD are 0.92%, illustrate that this law has the good response rate.
Table 14 recovery test
2.3.5, specificity
Take ERPIXING KELI and negative sample and prepare sample solution and negative sample solution by need testing solution preparation method,
By above-mentioned chromatographic condition, take reference substance solution, sample solution, negative sample solution injection chromatograph of liquid, sample solution respectively
Chromatograph is equipped with corresponding chromatographic peak in reference substance solution chromatograph corresponding positions, and negative noiseless, and result is shown in Figure 11, Figure 12 and Tu
13。
2.3.6, ruggedness,
2.3.6.1, the selection of sample extraction solvent
Get it filled composition granule, finely ground, take 4 parts, every part of about 2g, accurately weighed, put in 25ml measuring bottle, be soluble according to organic acid
Water, methanol, the character of ethanol, therefore precision addition suitable quantity of water, 1% sodium bicarbonate water, methanol, ethanol respectively, weighed weight, ultrasonic
Process 1 hour, let cool, respectively with water, 1% sodium bicarbonate water, methanol, ethanol dilution to scale, shake up, filter, take subsequent filtrate,
Cross 0.45 μm microporous filter membrane, as need testing solution.Take respectively above-mentioned solution each 20 μ l inject chromatograph of liquid, by methanol,
The poor content that cannot calculate of chromatogram separating effect that ethanol extraction obtains, therefore water and 1% sodium bicarbonate water are compared, meter
Calculating, the results are shown in Table 15, this product is adopted and is used water as Extraction solvent, and content extracts more complete.
The selection of table 15 Extraction solvent
2.3.6.2, the selection of sample extraction method
Get it filled composition granule, finely ground, take 3 parts, every part of about 2g, accurately weighed, precision adds 25ml water respectively, passes through back respectively
Stream, ultrasonic, soak extraction, weighed weight, refluxes 1 hour, ultrasonic 1 hour, soaks 1 hour, let cool, supply less loss with water respectively
Weight, filters, and takes subsequent filtrate, crosses 0.45 μm microporous filter membrane, as need testing solution.Take each 20 μ l of above-mentioned solution respectively and inject liquid
Chromatography, calculates, the results are shown in Table 16, backflow, ultrasonic, soak the content that three kinds of extracting method are surveyed and be more or less the same, therefore select
Simplicity, the preferable supersound extraction of effect are as extracting method.
The selection of table 16 extracting method
2.3.6.3, sample extraction time effects
Get it filled composition granule, finely ground, take 4 parts, every part of about 2.0g, accurately weighed, put in 25ml measuring bottle respectively, accurate add water
In right amount, ultrasonic 10,20,40,60 minutes respectively, let cool, be diluted with water to scale, shake up, filter, take subsequent filtrate, cross 0.45 μm
Microporous filter membrane, as need testing solution.Take each 20 μ l of above-mentioned solution respectively and inject chromatograph of liquid, calculate, the results are shown in Table 17,
10,20,40,60 minutes measured content is more or less the same, and in order to ensure to extract completely, therefore the selective extraction time is 20 minutes.
Table 17 extraction time affects
Extracting method is defined as: composition granule of getting it filled, finely ground, and precision weighs about 2.0g, puts in 25ml measuring bottle, accurate addition water
In right amount, supersound process (power 250W, frequency 30kHz) 20 minutes, let cool, be diluted with water to scale, shake up, filter, take continuous filter
Liquid, crosses 0.45 μm microporous filter membrane, to obtain final product.
2.3.6.4, the impact of different brands pillar
Using different brands octadecylsilane chemically bonded silica is the pillar of filler, determines respectively in ERPIXING KELI
The content of citric acid, investigates the impact of the chromatographic column of different brands.Assay the results are shown in Table 18.Result shows different brands ten
Eight alkyl silane bonded silica gels be filler chromatographic column on assay without impact.
The measurement result of table 18 different brands chromatographic column
2.3.6.5, sample stability test
Take ERPIXING KELI, prepare by need testing solution preparation method, measure citric acid peak area by above-mentioned chromatographic condition,
The results are shown in Table 19.
Table 19 sample stability is tested
2.4.10 batch content sample determination:
The results are shown in Table 20.
Table 20 10 batch sample assay result
According to 10 batch sample measured values, this product Fructus Crataegi assay limit is: this product every bag contains Fructus Crataegi with citric acid
(C6H8O7) meter, 6.0mg must not be less than.
The beneficial effects of the present invention is: the invention provides the detection method of a kind of ERPIXING KELI, including with effectively
Composition Hesperidin and citric acid are index, use high effective liquid chromatography for measuring Hesperidin and the content of citric acid;And medicine
In thin-layer identification method to Fructus Crataegi, Pericarpium Citri Reticulatae, Rhizoma Dioscoreae and Endothelium Corneum Gigeriae Galli;Described detection method is accurate, highly sensitive, reproducible,
Testing result is stable, can effectively control the quality of ERPIXING KELI, both be more beneficial for manufacturer and supervisory and management department to product
The monitoring of quality, it is also possible to the treatment for medical department and patient provides preferably guarantee.
Accompanying drawing explanation
When Fig. 1 is hawthorn thin-layer discriminating, during specificity test, under daylight, inspect figure;1-20151001,2-20151002,
3-20151003,4-negative sample, 5-Fructus Crataegi control medicinal material, 6-ursolic acid reference substance;
When Fig. 2 is hawthorn thin-layer discriminating, during specificity test, under ultra-violet lamp (365nm), inspect figure;1-20151001,
2-20151002,3-20151003,4-negative sample, 5-Fructus Crataegi control medicinal material, 6-ursolic acid reference substance;
When Fig. 3 is hawthorn thin-layer discriminating, during specificity test, under daylight, inspect figure;1-20151001,2-20151002,
3-20151003,4-negative sample, 5-Pericarpium Citri Reticulatae control medicinal material, 6-Hesperidin reference substance;
When Fig. 4 is the discriminating of Rhizoma Dioscoreae thin layer;During specificity test, under daylight, inspect result figure, 1-20151001,2-
20151002,3-20151003,4-Rhizoma Dioscoreae control medicinal material, 5-negative sample;
When Fig. 5 is the discriminating of Endothelium Corneum Gigeriae Galli thin layer, during specificity test, under daylight, inspect result figure;1-20151001,2-
20151002,3-20151003,4-Endothelium Corneum Gigeriae Galli control medicinal material, 5-negative sample;
Fig. 6 is Hesperidin canonical plotting, X-axis be sample size (μ g), Y-axis be peak area;
Fig. 7 is citric acid canonical plotting, X-axis be sample size (μ g), Y-axis be peak area;
When Fig. 8 is content of hesperidin mensuration, Hesperidin reference substance specificity lab diagram;
When Fig. 9 is content of hesperidin mensuration, Hesperidin test sample specificity lab diagram;
When Figure 10 content of hesperidin measures, Hesperidin negative sample specificity lab diagram;
When Figure 11 is citric acid assay, citric acid reference substance specificity lab diagram;
When Figure 12 is citric acid assay, citric acid test sample specificity lab diagram;
When Figure 13 is citric acid assay, citric acid negative sample specificity lab diagram.
Below in conjunction with embodiment, the present invention is further illustrated
Detailed description of the invention
Embodiment: the detection method of granule
Granular formulations: Fructus Crataegi 320g, Fructus Hordei Germinatus 320g, Endothelium Corneum Gigeriae Galli 240g, Rhizoma Dioscoreae 240g, Semen Coicis 160g, Semen Lablab Album
240g, Pericarpium Citri Reticulatae 96g and Poria 96g.
Technique: above eight tastes, Fructus Crataegi, tangerine peel powder are broken into coarse powder, use 65% ethanol as solvent, after impregnating 24 hours, carry out
Percolation, collects liquid of filtering, and diacolation liquid recycling ethanol, when being concentrated into 55-65 DEG C, relative density is the thick paste of 1.35-1.40, standby;Remaining
The Six-element medical material boilings such as Fructus Hordei Germinatus three times, each 1 hour, collecting decoction, filter, it is 1.10 that filtrate is concentrated into relative density
The clear paste of (60 DEG C), adds equivalent ethanol and makes precipitation, takes supernatant, reclaims ethanol, and being concentrated into relative density is the thick of 1.35-1.40
Cream;With above-mentioned Fructus Crataegi, the mixing of Pericarpium Citri Reticulatae thick paste, add sucrose in right amount, make granule, be dried, to obtain final product.
Usage and consumption: warm boiled water.1~5 years old one time 1 bag, 3 times on the one;5 years old with last 2 bags, 3 times on the one;10
It is a course for the treatment of.
Specification: every packed 2.5g.
Detection method:
Character: medicine is the granule of brown color;Feeble QI is fragrant, sweet and sour, micro-hardship.
Differentiate:
(1) get it filled composition granule content, finely ground after, take 8g and add 25ml ether, be heated to reflux 1 hour, filter, filtrate is waved
Dry, residue adds methanol 1m1 makes dissolving, as need testing solution;Separately take Fructus Crataegi control medicinal material 0.2g, finely ground after, take 8g and add 25ml
Ether, is heated to reflux 1 hour, filters, and filtrate volatilizes, and residue adds methanol 1m1 makes dissolving, prepares control medicinal material solution;Take Bears again
Fruit acid reference substance is appropriate, adds methanol and makes every 1ml solution containing 0.1mg, as reference substance solution;According to Chinese Pharmacopoeia thin layer color
Spectrometry is tested, and draws above-mentioned three all solution each 5~10 μ l, puts respectively on same silica gel g thin-layer plate, with toluene: acetic acid second
Ester: formic acid=20: be developing solvent at 4: 0.5, launches, takes out, dry, and spray is with ethanol solution of sulfuric acid (3 → 10), 105 DEG C of heating
Clear to spot development, put respectively and inspect under daylight or 365nm ultra-violet lamp, in test sample chromatograph, with control medicinal material chromatograph
On corresponding position, the principal spot of aobvious same color or fluorescence principal spot;On position corresponding with reference substance chromatograph, aobvious identical
The speckle of color or fluorescence speckle.
(2) get it filled composition granule content, finely ground after, take 10g, add methanol 30ml, be heated to reflux 1 hour, filter, filtrate is waved
Dry, the residue 10ml that adds water makes dissolving, is transferred in separatory funnel, extracts 2 times with ethyl acetate shaking, each each 10ml, merge
Acetic acid ethyl acetate extract, water-bath is evaporated, and residue adds methanol 2ml makes dissolving, as need testing solution;Separately take Pericarpium Citri Reticulatae control medicinal material
1g, is made in the same way of control medicinal material solution;Take Hesperidin reference substance more appropriate, add methanol and make saturated solution, molten as reference substance
Liquid;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above-mentioned three kinds of solution each 2~5 μ l, put respectively and use 0.5% hydrogen in same
On silica gel g thin-layer plate prepared by sodium hydroxide solution, with ethyl acetate: methanol: water=100: 17: 13 as developing solvent, Zhan Zhiyue
3cm, takes out, dries, then with toluene: ethyl acetate: formic acid: water=20: the upper solution of 10: 1: 1, as developing solvent, is opened up to 8cm,
Taking out, dry, spray is with 5% aluminum chloride ethanol solution, and being placed in wavelength is to inspect under 365nm ultra-violet lamp;In test sample chromatograph,
On position corresponding with control medicinal material chromatograph, the fluorescence principal spot of aobvious same color;In position corresponding with reference substance chromatograph
On, the fluorescence speckle of aobvious same color.
(3) get it filled composition granule content, finely ground, take 5g, add water 30ml, steeped overnight, and aqueous solution moves together with residue
Put in separatory funnel, add the shaking of water saturated n-butyl alcohol and extract 3 times, each 20ml, divide and take n-butyl alcohol liquid, be evaporated, residue adds suitable
Amount methanol makes dissolving, is added on the neutral alumina column of 100-120 mesh, 5g, internal diameter 10-15mm, washes with 10% methanol 100ml
De-, to collect eluent, be evaporated, residue adds 1ml70% ethanol makes dissolving, as need testing solution;Separately take Endothelium Corneum Gigeriae Galli control medicinal material
1g, add water 30ml, decocts 2 hours, and aqueous solution, together with in residue dislocation separatory funnel, is made in the same way of control medicinal material solution;
Test according to Chinese Pharmacopoeia thin layer chromatography, draw above two solution each 3~5 μ l, put respectively in same silica gel g thin-layer plate
On, with n-butyl alcohol: glacial acetic acid: water=9: 3: 1 as developing solvent, the lamellae after pre-equilibration point sample 15 minutes, launches, takes out, dry in the air
Dry, spray, with ninhydrin solution, is heated to spot development at 110 DEG C clear;In test sample chromatograph, corresponding to control medicinal material chromatograph
Position on, the principal spot of aobvious same color.
Every regulation relevant under (four annex I C of " Chinese Pharmacopoeia " version in 2015) granule item should be met.
Assay:
(1) Hesperidin:
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica as filler;With methanol: ice vinegar
Acid: water=35: be flowing phase at 4: 61;Column temperature is 35 DEG C;Detection wavelength is 283nm;Number of theoretical plate presses the calculating of Hesperidin peak should not
Less than 3000;
The preparation of reference substance solution: take Hesperidin reference substance appropriate, accurately weighed, add methanol and make every 1ml containing 0.01mg
Solution, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, mixing, finely ground, take 0.4g, accurately weighed, put tool plug cone
In shape bottle, accurate addition methanol 25ml, close plug, weighed weight, supersound process, sonification power is 250W, supersound process frequency
Rate is 35kHz, and sonication treatment time is 30 minutes, lets cool, more weighed weight, supplies the weight of less loss with methanol, shakes up, filter
Cross, take subsequent filtrate, to obtain final product;
Algoscopy: precision draws reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures,
Obtain.
This product every bag contains Pericarpium Citri Reticulatae with Hesperidin (C28H34O15) meter, 0.62mg must not be less than.
(2) citric acid: according to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: be filler with octadecylsilane chemically bonded silica;With 5% biphosphate
Ammonium salt solution (saving pH to 3.0 with phosphoric acid slow-readjustment) is flowing phase, and column temperature is 25 DEG C;Detection wavelength is 210nm;Number of theoretical plate presses citron
Acid peak calculates and should be not less than 3000;
The preparation of reference substance solution: take citric acid reference substance appropriate, accurately weighed, add water and make molten containing 0.3mg of every 1ml
Liquid, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, finely ground, precision weighs 2.0g, puts in 25ml measuring bottle, accurate
Adding water appropriate, supersound process, sonification power is 250W, and supersound process frequency is 35kHz, and sonication treatment time is 20 points
Clock, lets cool, and is diluted with water to scale and shakes up, and filters, and takes subsequent filtrate, crosses 0.45 μm microporous filter membrane, to obtain final product.
Algoscopy: precision draws reference substance solution and each 20 μ l of need testing solution respectively, injects chromatograph of liquid, measures,
Obtain.
This product every bag contains Fructus Crataegi with citric acid (C6H8O7) meter, 6.0mg must not be less than.
Claims (10)
1. a detection method for ERPIXING KELI, described granule is mainly by the Fructus Crataegi 300-340 part calculated by weight, Fructus Hordei Germinatus
300-340 part, Endothelium Corneum Gigeriae Galli 220-260 part, Rhizoma Dioscoreae 220-260 part, Semen Coicis 140-180 part, Semen Lablab Album 220-260 part, Pericarpium Citri Reticulatae
86-106 part and Poria 86-106 part are made as follows: above eight tastes, and Fructus Crataegi, tangerine peel powder are broken into coarse powder, use 65% ethanol
Making solvent, after impregnating 24 hours, carry out percolation, collect liquid of filtering, diacolation liquid recycling ethanol, when being concentrated into 55-65 DEG C, relative density is
1.35-1.40 thick paste, standby;The Six-element medical material boilings such as remaining Fructus Hordei Germinatus three times, each 1 hour, collecting decoction, filter,
When filtrate is concentrated into 55-65 DEG C, relative density is the clear paste of 1.10, adds equivalent ethanol and makes precipitation, takes supernatant, reclaims ethanol, dense
It is reduced to the thick paste that relative density is 1.35-1.40;With above-mentioned Fructus Crataegi, the mixing of Pericarpium Citri Reticulatae thick paste, add sucrose in right amount, make granule,
It is dried, to obtain final product;It is characterized in that: described detection method includes discrimination method and content assaying method;Described discrimination method includes
The thin layer of Fructus Crataegi, Pericarpium Citri Reticulatae, Rhizoma Dioscoreae or Endothelium Corneum Gigeriae Galli is differentiated detection;Described content assaying method includes Hesperidin or citric acid
Assay.
2. the detection method of ERPIXING KELI as claimed in claim 1, it is characterised in that: the discrimination method of described Fructus Crataegi is:
Get it filled composition granule, finely ground after, take 4-12g and add 20-30ml ether, be heated to reflux 0.5-1.5 hour, filter, filtrate volatilizes, residue
Add methanol 0.5-1.5m1 and make dissolving, as need testing solution;Separately take Fructus Crataegi control medicinal material 0.1-0.3g, finely ground after, take 4-12g
Adding 20-30ml ether, be heated to reflux 0.5-1.5 hour, filter, filtrate volatilizes, and residue adds methanol 0.5-1.5m1 makes dissolving, system
Obtain control medicinal material solution;Take ursolic acid reference substance more appropriate, add methanol and make every 0.5-1.5ml solution containing 0.05-0.15mg,
As reference substance solution;According to Chinese Pharmacopoeia thin layer chromatography test, draw above-mentioned three all solution each 5-10 μ l, put respectively in
On same silica gel g thin-layer plate, with toluene: ethyl acetate: formic acid=15-25: 2-6: 0.1-1.0, as developing solvent, launches, and takes out,
Drying, spray with ethanol solution of sulfuric acid, in ethanol solution of sulfuric acid, sulphuric acid is 2-4:9-11 with the volume ratio of ethanol;105 DEG C of heating
Clear to spot development, put respectively and inspect under daylight or 360-370nm ultra-violet lamp, in test sample chromatograph, with control medicinal material
On the corresponding position of chromatograph, the principal spot of aobvious same color or fluorescence principal spot;On position corresponding with reference substance chromatograph, aobvious
The speckle of same color or fluorescence speckle.
3. the detection method of ERPIXING KELI as claimed in claim 2, it is characterised in that: the discrimination method of described Fructus Crataegi is:
Get it filled composition granule, finely ground after, take 8g and add 25ml ether, be heated to reflux 1 hour, filter, filtrate volatilizes, and residue adds methanol 1m1 to be made
Dissolve, as need testing solution;Separately take Fructus Crataegi control medicinal material 0.2g, finely ground after, take 8g and add 25ml ether, be heated to reflux 1 hour,
Filtering, filtrate volatilizes, and residue adds methanol 1m1 makes dissolving, prepares control medicinal material solution;Take ursolic acid reference substance more appropriate, add first
Every 1ml solution containing 0.1mg made by alcohol, as reference substance solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above-mentioned three
All solution each 5~10 μ l, puts on same silica gel g thin-layer plate, respectively with toluene: ethyl acetate: formic acid=20: be at 4: 0.5
Developing solvent, launches, and takes out, dries, and sprays with ethanol solution of sulfuric acid, and in ethanol solution of sulfuric acid, sulphuric acid is 3 with the volume ratio of ethanol:
10;It is heated to spot development at 105 DEG C clear, puts respectively and inspect under daylight or 365nm ultra-violet lamp, in test sample chromatograph,
On position corresponding with control medicinal material chromatograph, the principal spot of aobvious same color or fluorescence principal spot;Corresponding to reference substance chromatograph
Position on, the speckle of aobvious same color or fluorescence speckle.
4. the detection method of ERPIXING KELI as claimed in claim 1, it is characterised in that: the discrimination method of described Pericarpium Citri Reticulatae is:
Get it filled composition granule, finely ground after, take 5-15g, add methanol 25-35ml, be heated to reflux 0.5-1.5 hour, filter, filtrate volatilizes, residual
The slag 5-15ml that adds water makes dissolving, is transferred in separatory funnel, extracts 2-3 time with ethyl acetate shaking, each each 5-15ml, merging
Acetic acid ethyl acetate extract, water-bath is evaporated, and residue adds methanol 1-4ml makes dissolving, as need testing solution;Separately take Pericarpium Citri Reticulatae comparison medicine
Material 0.5-1.5g, is made in the same way of control medicinal material solution;Take Hesperidin reference substance more appropriate, add methanol and make saturated solution, as
Reference substance solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above-mentioned three kinds of solution each 2-5 μ l, put respectively in same use
On silica gel g thin-layer plate prepared by 0.1-1.0% sodium hydroxide solution, with ethyl acetate: methanol: water=95-105: 15-19: 10-
16 is developing solvent, opens up to 1-6cm, takes out, dry, then with toluene: ethyl acetate: formic acid: water=15-25: 5-15: 0.5-1.5:
The upper solution of 0.5-1.5 is developing solvent, opens up to 5-10cm, takes out, dry, and spray, with 1-10% aluminum chloride ethanol solution, is put
Inspect under wavelength is 360-370nm ultra-violet lamp;In test sample chromatograph, on position corresponding with control medicinal material chromatograph, aobvious
The fluorescence principal spot of same color;On position corresponding with reference substance chromatograph, the fluorescence speckle of aobvious same color.
5. the detection method of ERPIXING KELI as claimed in claim 1, it is characterised in that: the discrimination method of described Endothelium Corneum Gigeriae Galli
For: composition granule of getting it filled, finely ground, take 1-10g, add water 25-35ml, steeped overnight, and aqueous solution leaks together with residue dislocation separatory
In bucket, add the shaking of water saturated n-butyl alcohol and extract 2-4 time, each 15-25ml, divide and take n-butyl alcohol liquid, be evaporated, residue adds appropriate first
Alcohol makes dissolving, is added on the neutral alumina column of 100-120 mesh, 1-10g, internal diameter 10-15mm, with 5-15% methanol 90-110ml
Eluting, collects eluent, is evaporated, and residue adds 0.5-1.5ml, 65-75% ethanol makes dissolving, as need testing solution;Separately take chicken
Endothelium corneum control medicinal material 0.5-1.5g, add water 25-35ml, decocts 1-3 hour, and aqueous solution is together with residue dislocation separatory funnel
In, it is made in the same way of control medicinal material solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above two solution each 3~5 μ l,
Put respectively on same silica gel g thin-layer plate, with n-butyl alcohol: glacial acetic acid: water=5-15: 1-6: 0.5-1.5 as developing solvent, pre-equilibration
Lamellae after point sample 10-20 minute, launches, and takes out, dries, and spray, with ninhydrin solution, is heated to spot development at 110 DEG C clear
Clear;In test sample chromatograph, on position corresponding with control medicinal material chromatograph, the principal spot of aobvious same color.
6. the detection method of ERPIXING KELI as claimed in claim 5, it is characterised in that: the discrimination method of described Endothelium Corneum Gigeriae Galli
For: composition granule of getting it filled, finely ground, take 5g, add water 30ml, steeped overnight, and aqueous solution, together with in residue dislocation separatory funnel, adds
The shaking of water saturated n-butyl alcohol is extracted 3 times, and each 20ml divides and takes n-butyl alcohol liquid, is evaporated, and residue adds proper amount of methanol makes dissolving, adds
In 100-120 mesh, 5g, internal diameter 10-15mm neutral alumina column on, with 10% methanol 100ml eluting, collect eluent, steam
Dry, residue adds 1ml70% ethanol makes dissolving, as need testing solution;Separately taking Endothelium Corneum Gigeriae Galli control medicinal material 1g, add water 30ml, decocts 2
Hour, aqueous solution, together with in residue dislocation separatory funnel, is made in the same way of control medicinal material solution;According to Chinese Pharmacopoeia thin layer color
Spectrometry is tested, and draws above two solution each 3~5 μ l, puts respectively on same silica gel g thin-layer plate, with n-butyl alcohol: glacial acetic acid:
Water=9: be developing solvent at 3: 1, the lamellae after pre-equilibration point sample 15 minutes launches, takes out, dry, sprays with ninhydrin solution,
110 DEG C to be heated to spot development clear;In test sample chromatograph, on position corresponding with control medicinal material chromatograph, aobvious same color
Principal spot.
7. the detection method of ERPIXING KELI as claimed in claim 1, it is characterised in that: described content of hesperidin assay method
For: according to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica as filler;With methanol: glacial acetic acid: water
=30-40: 1-8: 55-65 is flowing phase;Column temperature is 33-37 DEG C;Detection wavelength is 280-286nm;Number of theoretical plate presses Hesperidin
Peak calculates should be not less than 3000;
The preparation of reference substance solution: take Hesperidin reference substance appropriate, accurately weighed, add methanol and make every 0.5-1.5ml and contain
The solution of 0.005-0.015mg, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, mixing, finely ground, take 0.2-0.6g, accurately weighed, put tool plug cone
In shape bottle, accurate addition methanol 20-30ml, close plug, weighed weight, supersound process, sonification power is 200-300W, ultrasonic
Process frequency is 30-40kHz, and sonication treatment time is 25-35 minute, lets cool, more weighed weight, supplies the weight of less loss with methanol
Amount, shakes up, and filters, takes subsequent filtrate, to obtain final product;
Algoscopy: precision draws reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, to obtain final product.
8. the detection method of ERPIXING KELI as claimed in claim 7, it is characterised in that: described content of hesperidin assay method
For: according to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica as filler;With methanol: glacial acetic acid: water
Be flowing phase at=35: 4: 61;Column temperature is 35 DEG C;Detection wavelength is 283nm;Number of theoretical plate is calculated should be not less than by Hesperidin peak
3000;
The preparation of reference substance solution: take Hesperidin reference substance appropriate, accurately weighed, add methanol and make molten containing 0.01mg of every 1ml
Liquid, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, mixing, finely ground, take 0.4g, accurately weighed, put tool plug conical flask
In, accurate addition methanol 25ml, close plug, weighed weight, supersound process, sonification power is 250W, and supersound process frequency is
35kHz, sonication treatment time is 30 minutes, lets cool, more weighed weight, supplies the weight of less loss with methanol, shakes up, and filters, takes
Subsequent filtrate, to obtain final product;
Algoscopy: precision draws reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, to obtain final product.
9. the detection method of ERPIXING KELI as claimed in claim 1, it is characterised in that: described citric acid content assaying method
For: according to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: be filler with octadecylsilane chemically bonded silica;Number of theoretical plate presses citric acid
Peak calculates should be not less than 3000;
The preparation of reference substance solution: take citric acid reference substance appropriate, accurately weighed, add water and make every 0.5-1.5ml containing 0.1-
The solution of 0.6mg, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, finely ground, precision weighs 1-4g, puts in 20-30ml measuring bottle, accurate
Adding water appropriate, supersound process, sonification power is 200-300W, and supersound process frequency is 30-40kHz, during supersound process
Between be 15-25 minute, let cool, be diluted with water to scale and shake up, filter, take subsequent filtrate, cross 0.35-0.55 μm microporous filter membrane, i.e.
?.
Algoscopy: precision draws reference substance solution and need testing solution each 15-25 μ l respectively, injects chromatograph of liquid, measures, i.e.
?.
10. the detection method of ERPIXING KELI as claimed in claim 1, it is characterised in that:
The discrimination method of described Fructus Crataegi is: after composition granule of getting it filled is finely ground, takes 8g and adds 25ml ether, is heated to reflux 1 hour, filters,
Filtrate volatilizes, and residue adds methanol 1m1 makes dissolving, as need testing solution;Separately take Fructus Crataegi control medicinal material 0.2g, finely ground after, take 8g
Adding 25ml ether, be heated to reflux 1 hour, filter, filtrate volatilizes, and residue adds methanol 1m1 makes dissolving, prepares control medicinal material solution;
Take ursolic acid reference substance more appropriate, add methanol and make every 1ml solution containing 0.1mg, as reference substance solution;According to Chinese Pharmacopoeia
Thin layer chromatography is tested, and draws above-mentioned three all solution each 5~10 μ l, puts respectively on same silica gel g thin-layer plate, with toluene:
Ethyl acetate: formic acid=20: be developing solvent at 4: 0.5, launches, takes out, dry, and spray is with ethanol solution of sulfuric acid, ethanol solution of sulfuric acid
Middle sulphuric acid is 3:10 with the volume ratio of ethanol;It is heated to spot development at 105 DEG C clear, puts daylight or 365nm ultraviolet light respectively
Inspect under lamp, in test sample chromatograph, on position corresponding with control medicinal material chromatograph, the principal spot of aobvious same color or fluorescence master
Speckle;On position corresponding with reference substance chromatograph, the speckle of aobvious same color or fluorescence speckle;
The discrimination method of described Pericarpium Citri Reticulatae is: composition granule content of getting it filled, finely ground after, take 10g, add methanol 30ml, be heated to reflux 1 little
Time, filtering, filtrate volatilizes, and the residue 10ml that adds water makes dissolving, is transferred in separatory funnel, extracts 2 times with ethyl acetate shaking, often
Secondary each 10ml, combined ethyl acetate extracting solution, water-bath is evaporated, residue adds methanol 2ml makes dissolving, as need testing solution;Separately
Take Pericarpium Citri Reticulatae control medicinal material 1g, be made in the same way of control medicinal material solution;Take Hesperidin reference substance more appropriate, add methanol and make saturated molten
Liquid, as reference substance solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above-mentioned three kinds of solution each 2~5 μ l, point respectively
On the same silica gel g thin-layer plate prepared with 0.5% sodium hydroxide solution, with ethyl acetate: methanol: water=100: be at 17: 13
Developing solvent, opens up to about 3cm, takes out, dry, then with toluene: ethyl acetate: formic acid: water=20: the upper solution of 10: 1: 1 is for exhibition
Opening agent, open up to 8cm, take out, dry, spray is with 5% aluminum chloride ethanol solution, and being placed in wavelength is to inspect under 365nm ultra-violet lamp;
In test sample chromatograph, on position corresponding with control medicinal material chromatograph, the fluorescence principal spot of aobvious same color;With reference substance color
Compose on corresponding position, the fluorescence speckle of aobvious same color;
The discrimination method of described Endothelium Corneum Gigeriae Galli is: composition granule of getting it filled, finely ground, takes 5g, and add water 30ml, steeped overnight, aqueous solution together with
In residue dislocation separatory funnel together, add the shaking of water saturated n-butyl alcohol and extract 3 times, each 20ml, divides and takes n-butyl alcohol liquid, steam
Dry, residue adds proper amount of methanol makes dissolving, is added on the neutral alumina column of 100-120 mesh, 5g, internal diameter 10-15mm, uses 10% first
Alcohol 100ml eluting, collects eluent, is evaporated, and residue adds 1ml70% ethanol makes dissolving, as need testing solution;Separately take Endothelium Corneum Gigeriae Galli
Control medicinal material 1g, add water 30ml, decocts 2 hours, and aqueous solution, together with in residue dislocation separatory funnel, is made in the same way of comparison medicine
Material solution;Test according to Chinese Pharmacopoeia thin layer chromatography, draw above two solution each 3~5 μ l, put respectively in same silica gel G
On lamellae, with n-butyl alcohol: glacial acetic acid: water=9: 3: 1 as developing solvent, the lamellae after pre-equilibration point sample 15 minutes, launches, takes
Going out, dry, spray, with ninhydrin solution, is heated to spot development at 110 DEG C clear;In test sample chromatograph, with control medicinal material color
Compose on corresponding position, the principal spot of aobvious same color;
Described content of hesperidin assay method is: according to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: with octadecylsilane chemically bonded silica as filler;With methanol: glacial acetic acid: water
Be flowing phase at=35: 4: 61;Column temperature is 35 DEG C;Detection wavelength is 283nm;Number of theoretical plate is calculated should be not less than by Hesperidin peak
3000;
The preparation of reference substance solution: take Hesperidin reference substance appropriate, accurately weighed, add methanol and make molten containing 0.01mg of every 1ml
Liquid, to obtain final product;
The preparation of need testing solution: composition granule content of getting it filled, mixing, finely ground, take 0.4g, accurately weighed, put tool plug conical flask
In, accurate addition methanol 25ml, close plug, weighed weight, supersound process, sonification power is 250W, and supersound process frequency is
35kHz, sonication treatment time is 30 minutes, lets cool, more weighed weight, supplies the weight of less loss with methanol, shakes up, and filters, takes
Subsequent filtrate, to obtain final product;
Algoscopy: precision draws reference substance solution and each 10 μ l of need testing solution respectively, injects chromatograph of liquid, measures, to obtain final product;
Described citric acid content assaying method is: according to Chinese Pharmacopoeia high effective liquid chromatography for measuring:
Chromatographic condition and system suitability: be filler with octadecylsilane chemically bonded silica;Molten with 5% ammonium dihydrogen phosphate
Liquid, is flowing phase with phosphoric acid slow-readjustment joint pH to 3.0, and column temperature is 25 DEG C;Detection wavelength is 210nm;Number of theoretical plate presses citric acid peak
Calculating should be not less than 3000;
The preparation of reference substance solution: take citric acid reference substance appropriate, accurately weighed, add water the solution making every 1ml containing 0.3mg,
Obtain;
The preparation of need testing solution: composition granule content of getting it filled, finely ground, precision weighs 2.0g, puts in 25ml measuring bottle, accurate addition
Water is appropriate, supersound process, and sonification power is 250W, and supersound process frequency is 35kHz, and sonication treatment time is 20 minutes,
Let cool, be diluted with water to scale and shake up, filter, take subsequent filtrate, cross 0.45 μm microporous filter membrane, to obtain final product.
Algoscopy: precision draws reference substance solution and each 20 μ l of need testing solution respectively, injects chromatograph of liquid, measures, to obtain final product.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610887034.6A CN106248860B (en) | 2016-10-11 | 2016-10-11 | A kind of youngster's spleen is waken up the detection method of particle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610887034.6A CN106248860B (en) | 2016-10-11 | 2016-10-11 | A kind of youngster's spleen is waken up the detection method of particle |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106248860A true CN106248860A (en) | 2016-12-21 |
CN106248860B CN106248860B (en) | 2018-05-29 |
Family
ID=57611409
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610887034.6A Active CN106248860B (en) | 2016-10-11 | 2016-10-11 | A kind of youngster's spleen is waken up the detection method of particle |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106248860B (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110470783A (en) * | 2019-08-05 | 2019-11-19 | 中南大学湘雅二医院 | A kind of quality determining method of double yellow blood-fat-lowering granules |
CN114137117A (en) * | 2021-11-29 | 2022-03-04 | 上海方予健康医药科技有限公司 | Method for determining content of citric acid or citrate in preparation |
CN114522211A (en) * | 2021-12-29 | 2022-05-24 | 江苏七○七天然制药有限公司 | Preparation and detection method of infant spleen-tonifying and digestion-promoting granules |
CN118409026A (en) * | 2024-07-02 | 2024-07-30 | 四平市食品药品检验所 | Identification and content determination method of infant spleen-strengthening pill |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101444604A (en) * | 2009-01-06 | 2009-06-03 | 贵州本草堂药业有限公司 | Chinese medicine granular formulation to therapy children anorexia and preparation method thereof and detection method |
CN102114155A (en) * | 2010-01-06 | 2011-07-06 | 山东明仁福瑞达制药有限公司 | Serial Chinese medicinal preparation for treating phaseolus cold and preparation process and quality control method thereof |
KR20160054753A (en) * | 2014-11-07 | 2016-05-17 | 건국대학교 산학협력단 | A method for identifying vinegar and a composition therefor |
-
2016
- 2016-10-11 CN CN201610887034.6A patent/CN106248860B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101444604A (en) * | 2009-01-06 | 2009-06-03 | 贵州本草堂药业有限公司 | Chinese medicine granular formulation to therapy children anorexia and preparation method thereof and detection method |
CN102114155A (en) * | 2010-01-06 | 2011-07-06 | 山东明仁福瑞达制药有限公司 | Serial Chinese medicinal preparation for treating phaseolus cold and preparation process and quality control method thereof |
KR20160054753A (en) * | 2014-11-07 | 2016-05-17 | 건국대학교 산학협력단 | A method for identifying vinegar and a composition therefor |
Non-Patent Citations (3)
Title |
---|
国家药典委员会: "《中华人民共和国药典 2015年版 一部》", 30 June 2015 * |
杨滨等: "高效液相色谱法测定山楂中枸橼酸的含量", 《中国药学杂志》 * |
童鑫等: "运脾颗粒的质量标准研究", 《中国中医药信息杂志》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110470783A (en) * | 2019-08-05 | 2019-11-19 | 中南大学湘雅二医院 | A kind of quality determining method of double yellow blood-fat-lowering granules |
CN110470783B (en) * | 2019-08-05 | 2021-07-16 | 中南大学湘雅二医院 | Quality detection method of Shuanghuang lipid-lowering granules |
CN114137117A (en) * | 2021-11-29 | 2022-03-04 | 上海方予健康医药科技有限公司 | Method for determining content of citric acid or citrate in preparation |
CN114522211A (en) * | 2021-12-29 | 2022-05-24 | 江苏七○七天然制药有限公司 | Preparation and detection method of infant spleen-tonifying and digestion-promoting granules |
CN118409026A (en) * | 2024-07-02 | 2024-07-30 | 四平市食品药品检验所 | Identification and content determination method of infant spleen-strengthening pill |
Also Published As
Publication number | Publication date |
---|---|
CN106248860B (en) | 2018-05-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105259295B (en) | Quality detection method for ginseng, cassia twig and poria cocos oral solution | |
CN107478762A (en) | The discriminating of children's compound the membrane of a chicken's gizzard chewable tablets and content assaying method | |
CN106248860A (en) | A kind of detection method of ERPIXING KELI | |
CN102854281B (en) | Detection method of sugar-free strong loquat syrup | |
CN106370749A (en) | Quality detection method of ginseng basis-consolidating oral solution | |
CN105301168B (en) | The detection method of dredging collateral resolving sputum capsule | |
CN109613166A (en) | A kind of head luxuriant growth Tongbian capsule quality determining method | |
CN108760945B (en) | Detection method of astragalus membranaceus and astragalus membranaceus leucocyte increasing capsule | |
CN107315061B (en) | A kind of detection method of alizarin root of Dahurian angelica Chinese materia medica preparation that treating uterus bleeding | |
CN108459090B (en) | Quality control method of Jichuan decoction composition | |
CN106198810B (en) | A kind of quality determining method of the Chinese medicine composition with treatment tumor chemoradiotherapy bone marrow suppression | |
CN108169403A (en) | A kind of quality determining method of eight-treasure soup formula particle | |
CN103163272B (en) | Quality control method of infant spleen tonifying medicament | |
CN109692291A (en) | Lung power cough mixture medicinal extract and application thereof and method of quality control | |
CN104155383B (en) | The detection method of blue or green Pu granule | |
CN106442843A (en) | Quality check method of children's granules for clearing heat from throat | |
CN108037200A (en) | A kind of quality determining method of Zishenningshenwan | |
CN101703610A (en) | Quality detection method of Qingnao antihypertensive tablet | |
CN106706835A (en) | Quality detection method of trollius chinensis bunge effervescent tablets | |
CN100540037C (en) | A kind of detection method of infantile lung clearing phlegm transforming preparation | |
CN104873686A (en) | Quality detection method for ginseng antler brain-boosting capsule | |
CN102138964A (en) | Quality control method of Tongbaole chewing tablet | |
CN103869000B (en) | A kind of detection method of drug combination preparation | |
CN101987115A (en) | Jade screen oral preparation as well as preparation method and detection method thereof | |
CN105842381A (en) | Detection method of Qigu capsule |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A detection method for Erpixing granules Effective date of registration: 20231106 Granted publication date: 20180529 Pledgee: Agricultural Bank of China Limited Guiyang Jiaxiu sub branch Pledgor: GUIZHOU RUNSHENG PHARMACY CO.,LTD. Registration number: Y2023520000063 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |